Viksit Bharat 2047: How India’s Healthcare Engine Is Gearing Up for a $450 Billion Future
Updated: May 10, 2025 19:20
Image Source: The United Indian
India’s healthcare sector is on a transformative journey, with projections to grow from $55 billion today to a staggering $450 billion by 2047. This ambitious roadmap is powered by innovation, policy reforms, and a focus on accessibility, quality, and affordability.
Key Highlights:
The Indian pharmaceutical industry, already exporting to over 200 countries, is set to expand its global footprint by leveraging strengths in APIs, finished dosages, clinical research, and pharmacovigilance.
Growth will be catalyzed by supportive policies like the U.S. Biosecure Act, which are expected to open new international markets and redefine global healthcare solutions.
The sector targets $130 billion by 2030, accelerating to $450 billion by 2047, with a strong emphasis on biosciences, digital health, and R&D.
Universal health insurance schemes and increased public spending (targeting 3% of GDP by 2025) aim to reduce out-of-pocket expenses and prevent poverty due to medical costs.
Bridging the urban-rural divide is a core priority, with technology-driven solutions such as telemedicine and digital health records enhancing access and engagement, especially in remote areas.
Quality standards will be institutionalized across products and services, supported by health technology assessments and regulatory reforms.
The roadmap envisions India as a global innovation hub, not just for generics but for affordable, high-quality health products and services, including traditional systems like AYUSH.
Investment in healthcare talent, local manufacturing, and public-private partnerships will underpin sustainable growth and export potential.
A culture of health and wellness, driven by education, awareness, and preventive care, will be fostered to maximize healthy life years and economic productivity.
Source: Economic Times Pharma, Bain & Company, NATHEALTH